Ob/Gyn Medical News about HSV-2

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Once Daily Valacyclovir for Reducing Viral Shedding in Subjects Newly Diagnosed with Genital Herpes
Infectious Diseases in Obstetrics and Gynecology, 08/11/09

Martens MG et al. – In the study, the frequency of total and subclinical HSV–2 shedding was greater than reported in earlier studies involving subjects with a history of symptomatic genital recurrences. The authors study is the first to demonstrate a significant reduction in viral shedding with valacyclovir 1 g daily compared to placebo in a population of subjects newly diagnosed with HSV–2 infection.

<< Previous
Maternal Insulin Sensitivity During Pregnancy Predicts Infant...

Next >>
Doppler and gray-scale sonographic classification of adnexal...

Concentrated and linked epidemics of both HSV-2 and HIV-1/HIV-2 infections in Senegal: public health impacts of the spread of HIV
International Journal of STD & AIDS, 10/30/09 Relevance Score: 80%

Comparison of Focus HerpesSelect(R) and KalonTM HSV-2 gG2 ELISA serological assays to detect herpes simplex virus type 2 antibodies in a South African population
Sexually Transmitted Infections, 10/22/09 Relevance Score: 80%

Vaccines and Microbicides Preventing HIV-1, HSV-2, and HPV Mucosal Transmission
Journal of Investigative Dermatology, 10/19/09 Relevance Score: 80%